HydroCision Granted Patent for Selective Tissue Removal

HydroCision was granted U.S. Patent No. 11,278,305, Selective Tissue Removal Treatment Device, for their TenJet device. TenJet is believed to be the first patented device allowing for the targeted removal of tendon tissue.

The patent covers the application of HydroCision's FluidJet technology for the treatment of chronic tendon pain. TenJet's...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us